Highlights NanoString Technologies, Inc.

Equities

NSTGQ

US63009R1095

Market Closed - OTC Markets Other stock markets 03:59:30 2024-05-01 pm EDT			5-day change	1st Jan Change
0.19 ^USD	-26.09%		-36.67%	-74.61%

Apr. 22	Bruker Agrees Signs Asset Purchase Deal With NanoString Technologies	MT
Apr. 19	Motion for Asset Sale Approved for NanoString Technologies, Inc.	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bruker Agrees Signs Asset Purchase Deal With NanoString Technologies	Apr. 22	MT
Bruker Corporation entered into an agreement to acquire Substantially all assets from NanoString Technologies, Inc. (OTCPK:NSTG.Q) for approximately $390 million.	Apr. 16	CI
North American Morning Briefing : Stocks Seen -2-	Apr. 02	DJ
Patient Square Capital, LP agreed to acquire Substantially all assets of global business operations from NanoString Technologies, Inc. (OTCPK:NSTG.Q) for approximately $220 million.	Mar. 09	CI
NanoString Starts Chapter 11 Bankruptcy; Exploring Strategic Options, Including Potential Sale	Feb. 05	MT
Nanostring Launches the CosMx 6,000 Plex RNA Assay and Showcases Whole Transcriptome Imaging Capability	Feb. 01	CI
NanoString Technologies, Inc. Releases the First Public Dataset of the Whole Transcriptome Obtained At True Single-Cell Resolution on the CosMx Spatial Molecular Imager	Jan. 07	CI
NanoString Technologies Withdraws Q4, Full-Year Outlook Following Jury's Verdict in Patent Dispute With 10x Genomics	Nov. 20	MT
NanoString Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 06	CI
Earnings Flash (NSTG) NANOSTRING TECHNOLOGIES Posts Q3 Revenue $48.1M, vs. Street Est of $48.1M	Nov. 06	MT
NanoString Technologies, Inc. Updates Earnings Guidance for the Year 2023	Nov. 06	CI
NanoString Technologies Preliminary Q3 Sales Top Guidance; EU Court Declines Second Injunction in 10x Genomics Dispute	23-10-10	MT
Nanostring Technologies, Inc. Provides Revenue Guidance for the Third Quarter of 2023	23-10-10	CI
NanoString Technologies Enters Partnership to Establish Joint Lab in Singapore for Complex Disease Research	23-10-03	MT
Genome Institute of Singapore, NanoString Technologies, Inc. and Next Level Genomics Establish Joint Lab to Advance Studies of Complex Diseases with Spatial Genomics	23-10-03	CI
NanoString Technologies to Appeal Preliminary Injunction Halting CosMx for RNA Sales in EU	23-09-19	MT
NanoString Technologies, Inc. Launches the Most Comprehensive Spatial Proteomics Panel Ever Offered	23-09-13	CI
NanoString Technologies Says Expanding Partnerships With Contract Research Organizations	23-09-07	MT
NanoString Expands Partnerships with Contract Research Organizations Making Spatial Molecular Imaging Tools Widely Available to Global BioPharma Researchers	23-09-07	CI
NanoString Technologies Platforms Deployed in Assessing Immune Response in Pig-to-Human Organ Transplants	23-08-22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights NanoString Technologies, Inc.

Equities

NSTGQ

US63009R1095

Highlights

Filters